Suppr超能文献

镓-68 DOTATOC正电子发射断层显像/X线计算机体层成像(PET/CT)引导下活检及冷冻消融联合活检标本放射自显影术治疗肿瘤性骨软化症

Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.

作者信息

Maybody Majid, Grewal Ravinder K, Healey John H, Antonescu Cristina R, Fanchon Louise, Hwang Sinchun, Carrasquillo Jorge A, Kirov Assen, Farooki Azeez

机构信息

Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, M276C, New York, NY, 10065, USA.

Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Cardiovasc Intervent Radiol. 2016 Sep;39(9):1352-7. doi: 10.1007/s00270-016-1350-1. Epub 2016 May 5.

Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by small benign tumors of mesenchymal origin also known as phosphaturic mesenchymal tumors mixed connective tissue variant. Excellent prognosis is expected with eradication of the culprit tumor. These small tumors are notoriously difficult to localize with conventional imaging studies; this often leads to an extensive work up and prolonged morbidity. We report a patient with clinical diagnosis of TIO whose culprit tumor was localized with Ga-68 DOTATOC PET/CT and MRI. Biopsy and cryoablation were performed under Ga-68 DOTATOC PET/CT guidance. Autoradiography of the biopsy specimen was performed and showed in situ correlation between Ga-68 DOTATOC uptake and histopathology with millimeter resolution.

摘要

肿瘤诱导的骨软化症(TIO)是一种罕见的副肿瘤综合征,由间充质起源的小良性肿瘤引起,也称为含磷间充质肿瘤混合结缔组织变体。根除罪魁祸首肿瘤有望获得良好的预后。这些小肿瘤用传统影像学检查很难定位;这常常导致广泛的检查和长期的发病。我们报告一例临床诊断为TIO的患者,其罪魁祸首肿瘤通过Ga-68 DOTATOC PET/CT和MRI定位。在Ga-68 DOTATOC PET/CT引导下进行活检和冷冻消融。对活检标本进行放射自显影,显示Ga-68 DOTATOC摄取与组织病理学之间在毫米分辨率下的原位相关性。

相似文献

1
Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.
Cardiovasc Intervent Radiol. 2016 Sep;39(9):1352-7. doi: 10.1007/s00270-016-1350-1. Epub 2016 May 5.
2
Diagnostic performance of Ga-DOTATOC PET/CT in tumor-induced osteomalacia.
Ann Nucl Med. 2021 Mar;35(3):397-405. doi: 10.1007/s12149-021-01575-x. Epub 2021 Feb 13.
3
Usefulness of Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia.
Sci Rep. 2021 Jan 19;11(1):1819. doi: 10.1038/s41598-021-81491-2.
4
Ga-DOTATATE for Tumor Localization in Tumor-Induced Osteomalacia.
J Clin Endocrinol Metab. 2016 Oct;101(10):3575-3581. doi: 10.1210/jc.2016-2052. Epub 2016 Aug 17.
5
Comparison of F-FDG PET/CT and Ga-DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia.
Orthop Surg. 2021 May;13(3):791-798. doi: 10.1111/os.12980. Epub 2021 Mar 11.
6
Reports of 17 Chinese patients with tumor-induced osteomalacia.
J Bone Miner Metab. 2017 May;35(3):298-307. doi: 10.1007/s00774-016-0756-9. Epub 2016 Apr 16.
7
Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.
J Clin Endocrinol Metab. 2013 Feb;98(2):687-94. doi: 10.1210/jc.2012-3642. Epub 2013 Jan 7.
9
Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4202-e4209. doi: 10.1210/clinem/dgab258.

引用本文的文献

2
Treatment Advances in Tumor-Induced Osteomalacia.
Calcif Tissue Int. 2025 Jan 4;116(1):24. doi: 10.1007/s00223-024-01317-x.
3
Emerging Role of Gallium-68 DOTANOC PET/CT Guided Radiofrequency Ablation in the Treatment of Tumor-induced Osteomalacia.
JCEM Case Rep. 2024 Apr 24;2(5):luae044. doi: 10.1210/jcemcr/luae044. eCollection 2024 May.
4
Preoperative evaluation and orthopedic surgical strategies for tumor-induced osteomalacia.
J Bone Oncol. 2024 Mar 28;45:100600. doi: 10.1016/j.jbo.2024.100600. eCollection 2024 Apr.
5
Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
J Intern Med. 2023 Mar;293(3):309-328. doi: 10.1111/joim.13593. Epub 2022 Dec 13.
6
Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.
Theranostics. 2022 Feb 14;12(5):2175-2204. doi: 10.7150/thno.67530. eCollection 2022.
7
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors.
Diagnostics (Basel). 2022 Feb 18;12(2):528. doi: 10.3390/diagnostics12020528.
8
Advanced Monte Carlo simulations of emission tomography imaging systems with GATE.
Phys Med Biol. 2021 May 14;66(10). doi: 10.1088/1361-6560/abf276.
9
Practice and prospects for PET/CT guided interventions.
Q J Nucl Med Mol Imaging. 2021 Mar;65(1):20-31. doi: 10.23736/S1824-4785.21.03291-X. Epub 2021 Jan 26.
10
New Therapies for Hypophosphatemia-Related to FGF23 Excess.
Calcif Tissue Int. 2021 Jan;108(1):143-157. doi: 10.1007/s00223-020-00705-3. Epub 2020 Jun 5.

本文引用的文献

2
Tumor-Induced Osteomalacia: an Up-to-Date Review.
Curr Rheumatol Rep. 2015 Jun;17(6):512. doi: 10.1007/s11926-015-0512-5.
6
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
Clin Nucl Med. 2015 Jan;40(1):e6-e10. doi: 10.1097/RLU.0000000000000460.
8
Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
Hum Pathol. 2013 Dec;44(12):2711-8. doi: 10.1016/j.humpath.2013.07.016. Epub 2013 Sep 20.
9
Successful treatment of tumor-induced osteomalacia with CT-guided percutaneous ethanol and cryoablation.
J Clin Endocrinol Metab. 2012 Oct;97(10):3421-5. doi: 10.1210/jc.2012-1719. Epub 2012 Jul 26.
10
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia.
J Bone Miner Metab. 2012 Jan;30(1):93-9. doi: 10.1007/s00774-011-0290-8. Epub 2011 Jul 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验